NOVANTRONE Side Effects

7014293-8 | Hepatic Function Abnormal, Oedema Peripheral, Prostate Cancer Metastatic, Renal Impairment
on Sep 20, 2010 Male patient from UNITED STATES , weighting 231.5 lb, was diagnosed with prostate cancer metastatic and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, oedema peripheral, prostate cancer metastatic, renal impairment. Novantrone dosage: .

7009580-3 | Cardiac Failure Congestive, Cardiomegaly, Conduction Disorder, Heart Rate Increased, Heart Valve Incompetence, Red Blood Cell Count Decreased, White Blood Cell Count Decreased
Patient was taking Novantrone (View Usage). Patient had the following side effects: cardiac failure congestive, cardiomegaly, conduction disorder, heart rate increased, heart valve incompetence, red blood cell count decreased, white blood cell count decreased on Sep 13, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 180.8 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?), neuralgia, thyroid disorder and. Novantrone dosage: . During the same period patient was treated with REBIF (View Rebif Review and Rebif Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), THYROLAR (View Thyrolar Review and Thyrolar Label ).

6984310-X | Hepatic Function Abnormal, Oedema Peripheral, Renal Impairment
Adverse event was reported on Sep 07, 2010 by a Male patient taking Novantrone (View Usage) (Dosage: ) . Location: UNITED STATES , 68 years of age, After Novantrone was administered, patient had the following side effects: hepatic function abnormal, oedema peripheral, renal impairment.

6981603-7 | Metastases To Bone, Metastases To Liver, Oesophageal Carcinoma
on Sep 10, 2010 Male patient from UNITED STATES , weighting 244.7 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: metastases to bone, metastases to liver, oesophageal carcinoma. Novantrone dosage: . During the same period patient was treated with CLADRIBINE (View Cladribine Review and Cladribine Label ), COPAXONE (View Copaxone Review and Copaxone Label ). Patient was hospitalized.


6954700-X | Cardiac Disorder, Cardiac Failure Congestive, Cardiomegaly, Conduction Disorder, Heart Rate Increased, Red Blood Cell Count Decreased, White Blood Cell Count Decreased
on Aug 22, 2010 Female patient from UNITED STATES , weighting 180.8 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?), neuralgia, thyroid disorder and was treated with Novantrone (View Usage). Patient had the following side effects: cardiac disorder, cardiac failure congestive, cardiomegaly, conduction disorder, heart rate increased, red blood cell count decreased, white blood cell count decreased. Novantrone dosage: . During the same period patient was treated with REBIF (View Rebif Review and Rebif Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), THYROLAR (View Thyrolar Review and Thyrolar Label ).

6941575-8 | Cardiac Disorder, Cardiac Failure Congestive, Cardiomegaly, Conduction Disorder, Heart Rate Increased, Red Blood Cell Count Decreased, White Blood Cell Count Decreased
Patient was taking Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: cardiac disorder, cardiac failure congestive, cardiomegaly, conduction disorder, heart rate increased, red blood cell count decreased, white blood cell count decreased on Aug 17, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 180.8 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?), neuralgia, thyroid disorder and. Novantrone dosage: . During the same period patient was treated with REBIF (View Rebif Review and Rebif Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), THYROLAR (View Thyrolar Review and Thyrolar Label ).

6936672-7 | Acute Promyelocytic Leukaemia, Cerebrovascular Accident, Cholecystitis, Deep Vein Thrombosis, Disseminated Intravascular Coagulation, Ejection Fraction Decreased, Electrocardiogram Abnormal, Hemiplegia, Pancytopenia
Adverse event was reported on Aug 05, 2010 by a Male patient taking Novantrone (View Usage) (Dosage: 12 Mg/m2, 1 In 3 M, Intravenous (not Otherwise Specified)) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 44 years of age, weighting 286.6 lb, Patient experienced the following unwanted or unexpected effects: acute promyelocytic leukaemia, cerebrovascular accident, cholecystitis, deep vein thrombosis (What is deep vein thrombosis?), disseminated intravascular coagulation, ejection fraction decreased, electrocardiogram abnormal, hemiplegia, pancytopenia. During the same period patient was treated with COPAXONE (Subcutaneous; 20 Mg Subcutaneous) (View Copaxone Review and Copaxone Label ). Patient was hospitalized.

6931520-3 | Cardiac Disorder, Cardiac Failure Congestive, Cardiomegaly, Conduction Disorder, Heart Rate Increased, Red Blood Cell Count Decreased, White Blood Cell Count Decreased
on Aug 11, 2010 Female patient from UNITED STATES , weighting 180.8 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?), neuralgia, thyroid disorder and was treated with Novantrone (View Usage). Patient had the following side effects: cardiac disorder, cardiac failure congestive, cardiomegaly, conduction disorder, heart rate increased, red blood cell count decreased, white blood cell count decreased. Novantrone dosage: . During the same period patient was treated with REBIF (View Rebif Review and Rebif Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), THYROLAR (View Thyrolar Review and Thyrolar Label ).

6907682-0 | Acute Leukaemia
on Jul 16, 2010 Male patient from CANADA , 63 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: acute leukaemia. Novantrone dosage: .

6907672-8 | Acute Leukaemia
Patient was taking Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia on Jul 16, 2010 from CANADA Additional patient health information: Female patient , 44 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: .

6907671-6 | Acute Leukaemia
Adverse event was reported on Jul 16, 2010 by a Male patient taking Novantrone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: CANADA , 28 years of age, Patient had the following side effects: acute leukaemia.

6907669-8 | Acute Leukaemia
on Jul 16, 2010 Female patient from CANADA , 32 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: acute leukaemia. Novantrone dosage: .

6907662-5 | Acute Leukaemia
on Jul 16, 2010 Male patient from CANADA , 58 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia. Novantrone dosage: .

6907661-3 | Acute Leukaemia
Patient was taking Novantrone (View Usage). Patient had the following side effects: acute leukaemia on Jul 16, 2010 from CANADA Additional patient health information: Female patient , 40 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: .

6907657-1 | Acute Leukaemia
Adverse event was reported on Jul 16, 2010 by a Male patient taking Novantrone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: CANADA , 51 years of age, After Novantrone was administered, patient had the following side effects: acute leukaemia.

6907618-2 | Acute Leukaemia
on Jul 16, 2010 Female patient from CANADA , 47 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia. Novantrone dosage: .

6907615-7 | Acute Leukaemia
on Jul 16, 2010 Female patient from CANADA , 30 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient had the following side effects: acute leukaemia. Novantrone dosage: .

6907614-5 | Acute Leukaemia
Patient was taking Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: acute leukaemia on Jul 16, 2010 from CANADA Additional patient health information: Male patient , 23 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: .

6907420-1 | Acute Leukaemia
Adverse event was reported on Jul 16, 2010 by a Female patient taking Novantrone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: CANADA , 52 years of age, Patient experienced the following unwanted or unexpected effects: acute leukaemia.

6907367-0 | Acute Leukaemia
on Jul 16, 2010 Male patient from CANADA , 53 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient had the following side effects: acute leukaemia. Novantrone dosage: .

6907366-9 | Acute Leukaemia
on Jul 16, 2010 Female patient from CANADA , 35 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: acute leukaemia. Novantrone dosage: .

6907365-7 | Acute Leukaemia
Patient was taking Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia on Jul 16, 2010 from CANADA Additional patient health information: Female patient , 34 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: .

6907364-5 | Acute Leukaemia
Adverse event was reported on Jul 16, 2010 by a Female patient taking Novantrone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: CANADA , 32 years of age, Patient had the following side effects: acute leukaemia.

6907258-5 | Acute Leukaemia
on Jul 16, 2010 Female patient from CANADA , 24 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: acute leukaemia. Novantrone dosage: .

6907257-3 | Acute Leukaemia
on Jul 16, 2010 Female patient from CANADA , 54 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia. Novantrone dosage: .

6907255-X | Acute Leukaemia
Patient was taking Novantrone (View Usage). Patient had the following side effects: acute leukaemia on Jul 16, 2010 from CANADA Additional patient health information: Female patient , 53 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: .

6907250-0 | Acute Leukaemia
Adverse event was reported on Jul 16, 2010 by a Female patient taking Novantrone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: CANADA , 48 years of age, After Novantrone was administered, patient had the following side effects: acute leukaemia.

6907244-5 | Acute Leukaemia
on Jul 16, 2010 Female patient from CANADA , 47 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia. Novantrone dosage: .

6907243-3 | Acute Leukaemia
on Jul 16, 2010 Female patient from CANADA , 45 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient had the following side effects: acute leukaemia. Novantrone dosage: .

6907215-9 | Acute Leukaemia
Patient was taking Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: acute leukaemia on Jul 16, 2010 from CANADA Additional patient health information: Female patient , 19 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: .

6907211-1 | Acute Leukaemia
Adverse event was reported on Jul 16, 2010 by a Female patient taking Novantrone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: CANADA , 59 years of age, Patient experienced the following unwanted or unexpected effects: acute leukaemia.

6907210-X | Acute Leukaemia
on Jul 16, 2010 Male patient from CANADA , 58 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient had the following side effects: acute leukaemia. Novantrone dosage: .

6906960-9 | Dysarthria, Musculoskeletal Disorder, Thyroid Disorder, Weight Increased
on Jul 21, 2010 Female patient from UNITED STATES , 39 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: dysarthria, musculoskeletal disorder, thyroid disorder, weight increased. Novantrone dosage: .

6906791-X | Acute Leukaemia
Patient was taking Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia on Jul 16, 2010 from CANADA Additional patient health information: Male patient , 45 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: .

6906239-5 | Acute Leukaemia
Adverse event was reported on Jul 16, 2010 by a Female patient taking Novantrone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: CANADA , 46 years of age, Patient had the following side effects: acute leukaemia.

6906231-0 | Acute Leukaemia
on Jul 16, 2010 Male patient from CANADA , 45 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: acute leukaemia. Novantrone dosage: .

6906228-0 | Acute Leukaemia
on Jul 16, 2010 Female patient from CANADA , 43 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia. Novantrone dosage: .

6906221-8 | Acute Leukaemia
Patient was taking Novantrone (View Usage). Patient had the following side effects: acute leukaemia on Jul 16, 2010 from CANADA Additional patient health information: Female patient , 47 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: .

6906209-7 | Acute Leukaemia
Adverse event was reported on Jul 16, 2010 by a Female patient taking Novantrone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: CANADA , 59 years of age, After Novantrone was administered, patient had the following side effects: acute leukaemia.

6906200-0 | Acute Leukaemia
on Jul 16, 2010 Female patient from CANADA , 59 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia. Novantrone dosage: .

6906171-7 | Acute Leukaemia
on Jul 16, 2010 Female patient from CANADA , 58 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient had the following side effects: acute leukaemia. Novantrone dosage: .

6906167-5 | Acute Leukaemia
Patient was taking Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: acute leukaemia on Jul 16, 2010 from CANADA Additional patient health information: Male patient , 61 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: .

6906097-9 | Acute Leukaemia
Adverse event was reported on Jul 16, 2010 by a Female patient taking Novantrone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: CANADA , 37 years of age, Patient experienced the following unwanted or unexpected effects: acute leukaemia.

6906072-4 | Acute Leukaemia
on Jul 16, 2010 Female patient from CANADA , 55 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient had the following side effects: acute leukaemia. Novantrone dosage: .

6906066-9 | Acute Leukaemia
on Jul 16, 2010 Female patient from CANADA , 45 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: acute leukaemia. Novantrone dosage: .

6906064-5 | Acute Leukaemia
Patient was taking Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia on Jul 16, 2010 from CANADA Additional patient health information: Male patient , 49 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: .

6906061-X | Acute Leukaemia
Adverse event was reported on Jul 16, 2010 by a Male patient taking Novantrone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: CANADA , 54 years of age, Patient had the following side effects: acute leukaemia.

6906055-4 | Acute Leukaemia
on Jul 16, 2010 Female patient from CANADA , 46 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: acute leukaemia. Novantrone dosage: .

6906051-7 | Acute Leukaemia
on Jul 16, 2010 Male patient from CANADA , 36 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia. Novantrone dosage: .

6906049-9 | Acute Leukaemia
Patient was taking Novantrone (View Usage). Patient had the following side effects: acute leukaemia on Jul 16, 2010 from CANADA Additional patient health information: Female patient , 21 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: .